Lockdowns Are Causing Obesity Heartburn Medicines Are In Short Supply
There is nothing but bad news for heartburn sufferers that can no longer find Zantac or alternative medicine as COVID-19 lockdowns are causing more people to develop heartburn and acid reflux disease
Monday, December 14, 2020 - Round two of mandatory lockdowns is currently underway, including the closure of thousands of restaurants and fitness clubs is causing people to change not only their lifestyles but also their eating and exercising habits. Millions of Americans in several highly-populated states like California, Michigan, and New York are no longer eating the healthy diets they were accustomed to, nor are they getting as much exercise. Doctors report that when the first lockdown was lifted, they saw an increase in individuals that were seeking prescriptions for antacid medicine like Zantac. They explained to them that the drug was recalled and removed from store shelves early in 2020 when the Food and Drug Administration (FDA) was informed that the Zantac and also all ranitidine medicines, were contaminated with NDMA, a known carcinogen. The FDA recommended that former Zantac patients switch to PPI drugs like Prilosec, Nexium, and others. These drugs, however, are under suspicion from medical experts of contributing to developing Type-2 diabetes. Doctors told the New York Times that they think the lockdowns, including working at home and spending more time with their spouse and children, are increasing the stress people are under and causing them to self-medicate by eating and drinking unhealthily. People under lockdown stress are drinking more alcohol and eating more fast-food delivery. People locked down at home also tend to smoke more and exercise less as their gyms have closed, and their routines are uprooted. Eating poorly and exercising less may cause an increase in obesity in the months to come. Zantac cancer lawyers offer a no obligation consultation before filing a claim.
One gastroenterologist in Massachusetts told the Times her thoughts on the approximately 25 percent increase in her patients complaining of heartburn and indigestion. The Times Reported: "I think part of it is the stress of everything going on in the world," said Dr. Lauren Bleich, a gastroenterologist in Acton, Mass., about 25 miles northwest of Boston, who said she had seen a 25 percent increase in patients reporting heartburn and similar symptoms. But she also said the coronavirus, which has uprooted people's normal lives and forced many to work from home, had led to many "dietary indiscretions," which are triggering these symptoms. "We're more lax than we used to be with alcohol or sweets or our comfort food," Dr. Bleich said. "And then there's the lack of activity or exercise. Weight gain definitely contributes to heartburn and acid reflux."
Hundreds of individuals that have taken Zantac regularly and for more than a year alleged the medicine caused them to develop a wide variety of cancer from stomach cancer to breast cancer, and have hired a Zantac Cancer Lawyer to help them file a claim against Sanofi, the maker of Zantac.
More Recent Heartburn MedicineLawsuit News:
- Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
- Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
- Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
- The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
- Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
- Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
- Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
- A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
- Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
- Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
- Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
- Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
- The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
- Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
- Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
- Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
- Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
- Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
- Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
- Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.